FEBS Letters is a not-for-profit society journal for the rapid publication of concise research reports that significantly impact and advance knowledge in the molecular life sciences. We offer expedited handling of manuscripts by Editors who are active scientists in your field.

FEBS Letters is a well-established, hybrid Open Access journal that publishes original research and review articles in biochemistry and molecular biology. Bringing together the most important developments in the molecular biosciences, FEBS Letters provides an international forum for Reviews, Research Articles, Research Letters, Communications ...

FEBS Letters is an experimental biology journal publishing research in all areas of the molecular life sciences, including biochemistry and molecular cell biology.

FEBS Letters is a not-for-profit society journal for the rapid publication of concise research reports that significantly impact and advance knowledge in the molecular life sciences. We offer expedited handling of manuscripts by Editors who are active scientists in your field.

FEBS Letters is a world-renowned journal for rapid publication of reports describing novel and specific biological or biochemical functions. FEBS Letters articles typically report or discuss novel findings, which appeal to a broad readership, and provide molecular mechanistic insight.

2024年12月23日 · To mark the 60 th anniversary of FEBS, FEBS Letters celebrated with a writing contest focussed on participants' visions of scientific societies in the year 2084. Here, we present the winning essay by Yussuf Ali (Jagiellonian University).

2024年5月24日 · FEBS Press is proud to present the Nobel Prize Collection, a broad reading list of seminal papers published in our four journals in research areas that have earned the Nobel Prize in recent years. Our Special Issue features seven Reviews authored by leading scientists working on the molecular mechanisms, pathways, and key factors involved in ...

2024年2月1日 · FEBS Letters congratulates Peter Murray and Arno Alpi, winners of the 2025 FEBS Letters Award, for their article Skraban-Deardorff intellectual disability syndrome-associated mutations in WDR26 impair CTLH E3 complex assembly!

2024年11月7日 · FEBS Letters. Volume 599, Issue 3 p. 415-435. Research Article. Open Access. Cordycepin generally inhibits growth factor signal transduction in a systems pharmacology study. Steven Lawrence, Steven Lawrence. School of Pharmacy, Biodiscovery Institute, University of Nottingham, UK.

6 天之前 · FEBS Letters is an experimental biology journal publishing research in all areas of the molecular life sciences, including biochemistry and molecular cell biology.